Related Experiment Videos
Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain)
M Urtasun1, A Sáenz, C Roudaut
1Department of Neurology, Hospital Ntra. Sra. Aránzazu, San Sebastián, Basque Country, Spain. murtasuno@meditex.es
Brain : a Journal of Neurology
|October 8, 1998
Summary
Limb-girdle muscular dystrophy (LGMD) in Guipúzcoa shows the highest prevalence due to a founder effect. A specific calpain-3 gene mutation is predominant in this Basque population, aiding precise clinical diagnosis.
Area of Science:
- Genetics
- Neurology
- Epidemiology
Background:
- Limb-girdle muscular dystrophy (LGMD) is a heterogeneous genetic syndrome with a similar phenotype.
- Advances in molecular genetics are rapidly changing the understanding of LGMD.
- Isolated populations may exhibit a higher accumulation of specific genetic disorders.
Purpose of the Study:
- To conduct an epidemiological study of LGMD in Guipúzcoa, a Basque province.
- To identify the genetic basis and prevalence of LGMD in this isolated population.
- To investigate the clinical characteristics associated with specific LGMD subtypes.
Main Methods:
- Epidemiological survey in Guipúzcoa to determine LGMD prevalence.
- Genetic studies to identify gene mutations in affected individuals.
- Clinical assessment of patients to correlate phenotype with genotype.
Main Results:
- The highest LGMD prevalence rate (69 per million) was found in Guipúzcoa.
- LGMD2A, caused by calpain-3 gene mutations, accounted for 38 cases.
- A specific calpain-3 mutation (exon 22, 2362AG-->TCATCT) predominant in Basque chromosomes suggests a founder effect.
Conclusions:
- LGMD in Guipúzcoa is largely driven by a founder effect with a predominant calpain-3 mutation.
- The homogeneity of calpain-3 related LGMD cases allows for precise clinical diagnosis.
- Understanding LGMD heterogeneity and population-specific mutations is crucial for diagnosis and research.